Phosphonate and bisphosphonate analogues of farnesyl pyrophosphate as potential inhibitors of farnesyl protein transferase

1998 ◽  
Vol 6 (6) ◽  
pp. 687-694 ◽  
Author(s):  
Sarah A Holstein ◽  
Diana M Cermak ◽  
David F Wiemer ◽  
Kriste Lewis ◽  
Raymond J Hohl
1992 ◽  
Vol 285 (1) ◽  
pp. 55-60 ◽  
Author(s):  
Y Yoo ◽  
S Watts ◽  
M Rechsteiner

Using oligonucleotide-mediated ‘loop-in’ mutagenesis strategies in M13, a heat-inducible ubiquitin (Ub) gene was extended by sequences coding for the C-terminal 11 amino acids of Ha-RAS. The resulting gene was transformed into AR13 and production of the Ub-peptide extension was induced by heat treatment. After one-step purification, the fusion protein (Ub-cRAS) was used as a substrate for farnesyl-protein transferase. Ub-cRAS was farnesylated on incubation in Xenopus egg extract or rabbit reticulocyte lysate. In contrast, when serine was substituted for the last cysteine in the RAS extension, transfer of the [3H]farnesyl group from [3H] farnesyl pyrophosphate to the modified Ub-cRAS was not observed. Farnesylation of Ub-cRAS permitted us to develop an easy membrane-binding assay for farnesyl-protein transferase enzyme activity. Using this assay, we partially purified the enzyme from rabbit reticulocyte lysate. We also detected methylation of the farnesylated Ub-cRAS terminus in Xenopus egg extract.


Tetrahedron ◽  
1993 ◽  
Vol 49 (27) ◽  
pp. 5917-5926 ◽  
Author(s):  
Sheo B. Singh ◽  
Deborah L. Zink ◽  
Jerrold M. Liesch ◽  
Michael A. Goetz ◽  
Rosalind G. Jenkins ◽  
...  

2019 ◽  
Vol 52 (3) ◽  
Author(s):  
Lin Yang ◽  
Jun Cheng Zhang ◽  
Wan Chen Li ◽  
Jing Tao Qu ◽  
Hao Qiang Yu ◽  
...  

2015 ◽  
Vol 22 (11) ◽  
pp. 1383-1399 ◽  
Author(s):  
Marketa Svarcova ◽  
Martin Kratky ◽  
Jarmila Vinsova
Keyword(s):  

2015 ◽  
Vol 11 (6) ◽  
pp. 573-579 ◽  
Author(s):  
Pedro Araújo ◽  
Luís da Silva ◽  
Joaquim Esteves da Silva

2020 ◽  
Vol 16 (4) ◽  
pp. 389-401 ◽  
Author(s):  
Hanane Boucherit ◽  
Abdelouahab Chikhi ◽  
Abderrahmane Bensegueni ◽  
Amina Merzoug ◽  
Jean-Michel Bolla

Background: The great emergence of multi-resistant bacterial strains and the low renewal of antibiotics molecules are leading human and veterinary medicine to certain therapeutic impasses. Therefore, there is an urgent need to find new therapeutic alternatives including new molecules in the current treatments of infectious diseases. Methionine aminopeptidase (MetAP) is a promising target for developing new antibiotics because it is essential for bacterial survival. Objective: To screen for potential MetAP inhibitors by in silico virtual screening of the ZINC database and evaluate the best potential lead molecules by in vitro studies. Methods: We have considered 200,000 compounds from the ZINC database for virtual screening with FlexX software to identify potential inhibitors against bacterial MetAP. Nine chemical compounds of the top hits predicted were purchased and evaluated in vitro. The antimicrobial activity of each inhibitor of MetAP was tested by the disc-diffusion assay against one Gram-positive (Staphylococcus aureus) and two Gram-negative (Escherichia coli & Pseudomonas aeruginosa) bacteria. Among the studied compounds, compounds ZINC04785369 and ZINC03307916 showed promising antibacterial activity. To further characterize their efficacy, the minimum inhibitory concentration was determined for each compound by the microdilution method which showed significant results. Results: These results suggest compounds ZINC04785369 and ZINC03307916 as promising molecules for developing MetAP inhibitors. Conclusion: Furthermore, they could therefore serve as lead molecules for further chemical modifications to obtain clinically useful antibacterial agents.


Sign in / Sign up

Export Citation Format

Share Document